ArticleJCI insight2023

Cell-based screen identifies porphyrins as FGFR3 activity inhibitors with therapeutic potential for achondroplasia and cancer.

Yun-Wen Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.